3',4'-Methylenedioxy-α-pyrrolidinopropiophenone

3',4'-Methylenedioxy-α-pyrrolidinopropiophenone (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills.^[3] It shares a similar chemical structure with α-PPP and MDPV,^[4][1][2] and has been shown to have reinforcing effects in rats.^[5]

MDPPP

Clinical data
Routes of administration	By mouth, insufflation, vaporization, IV, rectal, sublingual
Legal status
Legal status	DE: Anlage I (Authorized scientific use only) UK: Class B
Pharmacokinetic data
Metabolism	Hepatic[1][2]
Excretion	Primarily urine (renal)
Identifiers
IUPAC name (RS)-1-(3,4-methylenedioxyphenyl)-2-(1-pyrrolidinyl)-1-propanone
CAS Number	783241-66-7
PubChem CID	6430845
ChemSpider	4936183
UNII	83IP4LIH8E
CompTox Dashboard (EPA)	DTXSID001024625
Chemical and physical data
Formula	C14H17NO3
Molar mass	247.294 g·mol−1
3D model (JSmol)	Interactive image
Chirality	Racemic mixture
SMILES c3c1OCOc1ccc3C(=O)C(C)N2CCCC2
InChI InChI=1S/C14H17NO3/c1-10(15-6-2-3-7-15)14(16)11-4-5-12-13(8-11)18-9-17-12/h4-5,8,10H,2-3,6-7,9H2,1H3 Key:NIYQOTCYXGXMPI-UHFFFAOYSA-N

Metabolism

MDPPP appears to have a similar metabolic fate as MDPV.^[2]

Legal Status

As of October 2015^[update] MDPPP is a controlled substance in China.^[6]

See also

• α-Pyrrolidinopropiophenone (α-PPP)
• 4'-Methyl-α-pyrrolidinopropiophenone (MPPP)
• 4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP)
• 3',4'-Methylenedioxy-α-pyrrolidinobutiophenone (MDPBP)
• Dimethylone